发明授权
US5874461A Use of Nebivolol as an anti-atherogenic 失效
使用内比洛尔作为抗动脉粥样硬化

Use of Nebivolol as an anti-atherogenic
摘要:
This invention relates to the use of an .alpha.,.alpha.'-iminobs(methylene)bis �2-chromanmethanol! derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stress.
公开/授权文献
信息查询
0/0